Our Partner

MISSION

dRx Capital AG is a joint investment company launched by Novartis and Qualcomm with a capital commitment up to $100M. dRx strives to catalyze the success of digital medicine products, services, and business models by investing in early-stage companies and leveraging our extensive networks in Pharma, Mobile/IT, and investment community.

TEAM

Our team is comprised of fund managers from both backers. The partners from Qualcomm also manage the Qualcomm Life Fund at Qualcomm Ventures which has been ranked as one of the most prolific venture investors in digital health, while the partners from Novartis bring in extensive business and clinical experience from a leader in the pharma industry.

FOCUS

Digital Health is a fast-evolving space, where Pharma stands to benefit from advancements. We are seeking entrepreneurs using digital technology to transform pharmaceutical products, sales and marketing, R&D, and enterprise operations. Together, we can improve the lives of patients and clinicians and usher in the era of digital medicine.

Meet Our Team

The partners from Qualcomm also manage the Qualcomm Life Fund at Qualcomm Ventures which has been ranked as one of the most prolific venture investors in digital health, while the partners from Novartis bring in extensive business and clinical experience from a leader in the pharma industry.

Neil Tiwari, BS, MS, MBA

Neil Tiwari, BS, MS, MBA

General Partner

Neil is a General Partner at dRx Capital. He is a healthcare technology leader with 10+ years of experience developing life sustaining . . .

Neil is a General Partner at dRx Capital. He is a healthcare technology leader with 10+ years of experience developing life sustaining medical devices, diagnostic devices, drug-device combination products and digital health products. His background in product development has allowed him to foster the growth of early stage companies both in the startup and academic environment. Neil has a BS and MS in Biomedical Engineering from Northwestern University and a MBA from the Berkeley Haas School of Business.

Aaron Nelson, MD, PhD

Aaron Nelson, MD, PhD

Advisor

Aaron is a General Partner at dRx Capital, as well as a Strategic Project Leader within the Trials of The Future team of Novartis Pharmaceuticals . . .

Aaron is a General Partner at dRx Capital, as well as a Strategic Project Leader within the Trials of The Future team of Novartis Pharmaceuticals. In recent years, Aaron has worked on technology strategy for clinical trial teams within Novartis. This work has led him to conclude that mobile, cloud, and Health IT technologies provide transformative opportunities in the clinical research and pharmaceutical industries. Aaron has led projects building upon these themes across multiple Business Units within Novartis, often by collaborations or investments in early-stage partner companies. Previously, Aaron led laboratory teams at Novartis, investigating the biological bases for drug toxicity. Aaron studied medicine at Tufts University, cell and microbiology at the University of Pennsylvania and the Karolinska Institute, and completed his undergraduate studies at Cornell University.

Request a Call Back

If you need to speak to us about a general query, fill in the form below and we will call you back within the same working day.

Our Portfolio

info@drxcapital.com
www.drxcapital.com